VEGFA and retinopathy of prematurity: Furthermore, the utility of VEGF inhibitors is well documented in other ocular diseases as wet age-related macular degeneration, retinopathy of prematurity (ROP), retinal vein occlusion, and proliferative diabetic retinopathy (Braithwaite et al. 2014; Martinez-Zapata et al. 2014; Sankar et al. 2018; Solomon et al. 2019, Wells et al. 2016).